Thursday, August 20, 2026. 12 PM-1:30 PM ET
Hear from an expert in HER2 IHC whose work has contributed to current scoring guidelines.
Webinar presenter Josef Ruschoff, MD, PhD, Former Chief Medical Officer and Co-Founder of Targos, Senior Consultant of Discovery Life Sciences, Kassel, Germany.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
To be rescheduled to a future date
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2026—Baebies Finder Flu A and B/SARS-CoV-2 test received FDA 510(k) clearance and CLIA waiver on the Finder platform. The compact, automated PCR system delivers positive results in as few as 15 minutes and negative results in about 20 minutes.
June 2026—RoboPath’s Robotic Archival and Retrieval System (RARS) automates archiving and retrieving of tissue sample slides using robotics and artificial intelligence.
June 2026—Illumina launched DRAGEN version 4.5 software, designed to deliver new ways to reduce noise, improve accuracy, and extract biological signals.
The following customer bulletin about A1CNow+ Controls (REF 737) is published at the request of Nova-One Diagnostics.
May 2026—Bruker’s microbiology and infection diagnostics division launched at ESCMID Global (April 17–21, Munich) the MyGenius Pro system in Europe.
May 2026—Sarstedt’s Tempus1800 sample transport system was awarded a Vizient innovative technology contract.
May 2026—City of Hope is implementing Quest Diagnostics’ Haystack MRD, a circulating-tumor DNA minimal residual disease test, for clinical trial patients with solid tumor cancers to help guide disease management for breast, colorectal, ovarian, and prostate cancer.
May 2026—Clinical Lab 2.0, an initiative of Project Santa Fe Foundation, is partnering with Life Data Lab, developer of Vivica LabReports, a laboratory platform that enables clinical labs to identify potential gaps in patient care (per provider request).
May 2026—Labcorp launched the Labcorp Fentanyl Urine Visual test for the assessment of fentanyl exposure. The test detects norfentanyl, which can remain present in urine up to 48 hours after initial exposure.
May 2026—Omnia Inventa Medical has introduced the Lymph Node Locator 300, an FDA class I, 510(k)-exempt device designed to standardize lymph node retrieval from fatty tissue in oncologic specimens.
